T. Rowe Price Associates’s Fresenius Medical Care FMS Stock Holding History

T. Rowe Price Associates’s Portfolio FMS Stock Details FMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20,758	Closed	-$726K	–	3004
2021 Q3	$726K	Sell	20,758 -17,616	-46%	-$688K	﹤0.01%	2199
2021 Q2	$1.59M	Sell	38,374 -3,978	-9%	-$159K	﹤0.01%	1838
2021 Q1	$1.56M	Buy	+42,352	New	+$1.6M	﹤0.01%	1826

Other funds holding FMS

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Cambiar Investors Denver, Colorado $2.16B AUM 16.24% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates's FMS Position: Q4 2021 in Review

T. Rowe Price Associates sold out of Fresenius Medical Care (FMS) in Q4 2021, closing a stake of 20,758 shares — an estimated $726K sold.

T. Rowe Price Associates first reported a position in FMS in Q1 2021 and held it in 3 quarters. The position peaked at $1.59M in Q2 2021. 173 funds tracked by Wall St. Rank hold FMS as of Q4 2021.

T. Rowe Price Associates reported no remaining Fresenius Medical Care position as of Q4 2021 after selling out during the quarter.
T. Rowe Price Associates sold 20,758 Fresenius Medical Care shares in Q4 2021, an estimated $726K.
T. Rowe Price Associates first reported a position in Fresenius Medical Care in Q1 2021 and held it in 3 quarters.
T. Rowe Price Associates's Fresenius Medical Care position peaked at $1.59M in Q2 2021.
173 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q4 2021.

Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.